Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Saturday, October 24, 2026

Back to today

From X

@DeepSailCapital

Deep Sail Capital on X

$CLBT - You can make a pretty compelling case that the guidance cut was to kitchen sink the expectations for the new CEO so he has a bottom base to build off of. From the call 4-5 major deals slipped out a quarter, and Genesis isn't ramping as fast as originally thought, but new products are growing +25% & they have tailwinds in terms of FedRamp & YoY US federal basically didn't grow last year. Next quarter they beat, and re-raise guidance and stock is back to $16. 50% return from here in a quarter. Clearly if they can't close deals in Q3 at a faster pace then the recovery takes longer, but seems like good risk-reward here. Full disclosure: I added some at $10.5
@leevalueroach

Lee Roach on X

I posted this mental model of $EVC in May when the stock was in high $7s. My price target for the company is $10 billion equity value or around $100 per share. Apparently some funds bought into Entravision based on this and didn’t do much of their own homework. I didn’t think I needed to say this but do your own homework if you buy a stock. I’m just some dude in rural America. I never went to college. Worked third shift in a factory all my adult life. Now I talk about stocks I like, invest my money and tweet jokes. That being said, nothing has changed with my thesis on Entravision being a potential multi-bagger. Q2 was an amazing quarter. Q3 will be an amazing quarter. You don’t measure a businesses success over a quarter, which it seems like many are doing. The best investing is done over long periods of time. Patience is the best tool for the best success. Tell me, has anything changed with the thesis? The industry is growing at a 30-50% annual rate. As long as Entravision can keep improving their models they will likely continue to grow at the industry rate. And over the past few years they have smoked the industry. One quarter of deceleration? Who cares. They probably had a model breakthrough in Q2 that accelerated revenues and I’m sure the World Cup also helped their CTV business. And to be frank, this management team is one of the most conservative teams I know. They literally start every call talking about the dying media business. Do the math on what Q4 implies if you think it’s over. Just do it. The DSP business model is one of the best I’ve ever seen. Low capital costs. Extremely high incremental margins. Scalable. Negative working capital. Back out of the media business and the spectrum assets - which are looking like they could get bid over near-term (near term is way different for me than Wall Street’s two second of pleasure btw) and you are buying Ad-Tech for an extremely low multiple, or close to nothing. I could be wrong. I don’t think there’s crazy downside here. But just remember, I’m not from the industry. I made bathtubs for a living until I started blogging. So definitely do you own research before buying blindly based on my thoughts. It is hilarious though that hedge funds were buying because of my research. Can’t wait to tell some of the guys at the shop I worked at about that. Over some Steel Reserve and Lucky Strike smokes, of course.

Investor Letters

All letters

MYR Group q3’26 Earnings Preview

MYR Group’s Q3 2026 preview cites data-center and power transmission demand, with long-term service agreements supporting margin growth and…

MYRG $4.2B
Monte Independent Investment Research 6 clicks

Mosaic, Part One: The Story

Mosaic’s history traces the 2004 Cargill-IMC merger and the phosphate and potash mines that shaped NYSE: MOS.

MOS $5.8B
Latticework by MOI Global 34 clicks

Mosaic, Part Two: The Deep Dive

Mosaic, NYSE: MOS, is the subject of a second audio program for professional investors analyzing fertilizer producers.

MOS $5.8B
Latticework by MOI Global 5 clicks

Unicycive (UNCY):

Unicycive’s oxylanthanum carbonate NDA earned a March 25, 2027 PDUFA date after two manufacturing-related rejections, with no FDA clinical…

UNCY $104M
Triple S Special Situations Investing 4 clicks
BMBL 2026-10-21

Bumble is being taken private

Bumble agreed to a $6.05-per-share cash sale to Ithaca Holdings, 136% above its October 2 share price.

BMBL $788M
Modern Value Investing 8 clicks
PYPD · long

Polypid LTD

PolyPid, an $80 million Israeli biotech, fell nearly 30% despite solving a clinical problem.

PYPD $114M
Value Investors Club

GLOO, part two

Gloo faces related-party deals, insider-heavy IPO ownership, acquisition losses and $84.5 million of CEO-backed puts as it burns cash and…

GLOO $274M
Guardian Research 4 clicks

Why I sold OB pick for 26 SVM

Silvercorp’s falling Ying grades, prolonged GC suspension, El Domo execution risk and Chaarat funding needs weaken its valuation despite…

SVM $1.9B
The Oak Bloke 27 clicks

Vicor Update, Part Three

Vicor’s $66.6 million in AI power-delivery royalties generated about $50 million of operating profit, eclipsing its module business as…

VICR $9.6B
CV's Substack 28 clicks

Carecloud News

CareCloud may attract a private-equity buyer after its Q3 call, with acquiring enough shares the main obstacle to a take-private deal.

CCLD $75M
Calvin Blissett 11 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 67 of 266

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.